FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Keeps Sell Opinion On Ads Of Fresenius Medical Care

By

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

We adjust our target price to USD19 from USD21, implying 8.2x of our 2026 EPADS, below its three-year historical forward P/E of 12.9x to reflect the long-term growth uncertainty on the back of the still elevated excess mortality rate. FME's Q1 2026 revenue fell 5.5% mainly due to currency headwinds, with organic growth remaining positive at 3.9%, while the operating margin (excluding special items) improved 0.7%-pts. The results were supported by FME25+ savings, the rollout of the 5008X CAREsystem, and the TDAPA reimbursement tailwinds. However, the U.S. same market treatment growth remained challenged, hit by missed treatments. FME reaffirmed its 2026 guidance, with 1H expecting to be stronger before TDAPA benefits phase out in 2H. We adjust our EPADS estimates to EUR1.98 from EUR2.03 for 2026 and to EUR2.16 from EUR2.20 for 2027 to account for the results. While the sustained FME25+ cost savings is positive, the timeline for U.S. same market volume recovery remains uncertain, which we see as a key concern.

Related Articles

Asia

Aurizon Holdings Welcomes Australia's AU$1.75 Billion Investment to Improve Freight Rail Network

Aurizon Holdings (ASX:AZJ) welcomed the AU$1.75 billion investment announced by the Australian government overnight to improve Australia's freight rail network, according to a Wednesday Australian bourse filing.The firm's Chief Executive, Andrew Harding, noted that increased extreme weather events, as well as the long-term deterioration of track infrastructure, led to an adverse impact on the rail industry in recent years.The government indicated the funds will be used for initiatives such as resilience upgrades in high-risk flood-prone areas of the network, as well as on track renewal works, passing loop extensions, and improved signalling.Harding added that the government's decision to pause work on the Inland Rail was prudent and fiscally responsible.

$ASX:AZJ
Equities

Dana Gas Partners With UK's Levidian for Graphene Production in UAE

Dana Gas (ADX:DANA) is collaborating with UK-based advanced materials company Levidian to produce graphene in Sharjah, United Arab Emirates.The partners plan to develop the Sharjah Graphene Park in phases, initially deploying Levidian's LOOP technology, which converts methane into graphene and hydrogen, to establish local production capability, the natural gas company said Wednesday. The project is expected to scale into a multi-unit production cluster following the initial phase.The first phase is estimated to cost between $2 million and $5 million, while early expansion could require $5 million to $50 million, with the potential to exceed $50 million as the project develops in line with market demand.

$ADX:DANA
Asia

Ora Banda Mining's Execution of Exploration Program Creates Strong Foundation for Self‐Funded Growth, Euroz Hartleys Says

Ora Banda Mining's (ASX:OBM) execution of its ambitious fiscal year 2026 exploration program established a solid foundation for self‐funded growth, Euroz Hartleys said in a May 5 note.The exploration program was underpinned by a budget of AU$73 million and roughly 330 kilometers of drilling, an investment that has already yielded a 57% boost in group resources to 3.3 million ounces with more near-term growth on the horizon, the equity research firm said.The company's Waihi gold prospect in Western Australia "is advancing rapidly from a small open pit to portal position for the next underground mine," Euroz Hartleys said.It added that the Riverina and Sand King underground mines are running at steady‐state and appear to be supporting long mine lives, with Sand King continuing to benefit from dual declines and a recent 25% uplift in mined ounces.Euroz Hartleys maintained a buy rating on Ora Banda and raised its price target to AU$1.92 per share from AU$1.88, saying the company "remains a compelling growth story leveraged to exploration success."

$ASX:OBM